SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 184.82-2.0%Dec 5 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David L. Hachey who wrote (18435)4/1/1998 1:53:00 PM
From: tuck  Read Replies (1) of 32384
 
David,

Ligand may want to keep their numbers to themselves for the time being. But there may be some papers accompanying Phase I/II trials that mention the spike in numbers, and whether or not a meal was part of the protocol. These may be in the public domain, and perhaps Henry knows where to look. For a couple of weeks I'll be out of touch with my source, who may or may not a) know the numbers, or b) feel at liberty to tell.

I would guess that Ligand's scientists didn't clutter the dose with a meal that would produce the same effect. A meal shouldn't be necessary for a small molecule drug, should it?

Regards, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext